Age: 59.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Rheumatoid arthritis, Stress, Therapeutic product effect incomplete, Therapeutic response shortened
Clinical narrative: Lack of drug effect; Tipula tear in left hip caused problem walking; Tipula tear in left hip caused problem walking; Felt ill; Feeling unwell; Stress; Depression; Pain in fingers; Pain Flare Up; Wearing off effect; Felt rheumatoid arthritis symptoms flare up two or three days before humira injection/humira seemed to wear off Prior to fourteen days; Bruise at injection site; Lower back pain flare up; Pustular skin eruption; Discomfort; Injection site burning; General body pain; Felt Humira was not working as well as it used to with humira 40mg/0 . 4ml (adalimumab); Injection site swelling; Headache; Nausea; This spontaneous case was reported by a physician and describes the occurrence of DRUG INEFFECTIVE (Lack of drug effect) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. On an unknown date, the patient experienced DRUG INEFFECTIVE (Lack of drug effect) (seriousness criterion medically significant), JOINT INJURY (Tipula tear in left hip caused problem walking), GAIT DISTURBANCE (Tipula tear in left hip caused problem walking), MALAISE (Felt ill), MALAISE (Feeling unwell), STRESS (Stress), DEPRESSION (Depression), PAIN IN EXTREMITY (Pain in fingers), PAIN (Pain Flare Up), THERAPEUTIC RESPONSE SHORTENED (Wearing off effect), RHEUMATOID ARTHRITIS (Felt rheumatoid arthritis symptoms flare up two or three days before humira injection/humira seemed to wear off Prior to fourteen days), INJECTION SITE BRUISING (Bruise at injection site), BACK PAIN (Lower back pain flare up), RASH PUSTULAR (Pustular skin eruption), DISCOMFORT (Discomfort), INJECTION SITE PAIN (Injection site burning), PAIN (General body pain), THERAPEUTIC PRODUCT EFFECT INCOMPLETE (Felt Humira was not working as well as it used to with humira 40mg/0 . 4ml (adalimumab)), INJECTION SITE SWELLING (Injection site swelling), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, DRUG INEFFECTIVE (Lack of drug effect), JOINT INJURY (Tipula tear in left hip caused problem walking), GAIT DISTURBANCE (Tipula tear in left hip caused problem walking), DEPRESSION (Depression), PAIN (Pain Flare Up), THERAPEUTIC RESPONSE SHORTENED (Wearing off effect), RHEUMATOID ARTHRITIS (Felt rheumatoid arthritis symptoms flare up two or three days before humira injection/humira seemed to wear off Prior to fourteen days), INJECTION SITE BRUISING (Bruise at injection site), BACK PAIN (Lower back pain flare up), RASH PUSTULAR (Pustular skin eruption), THERAPEUTIC PRODUCT EFFECT INCOMPLETE (Felt Humira was not working as well as it used to with humira 40mg/0 . 4ml (adalimumab)) and INJECTION SITE SWELLING (Injection site swelling) had not resolved, MALAISE (Felt ill), PAIN IN EXTREMITY (Pain in fingers), PAIN (General body pain), HEADACHE (Headache) and NAUSEA (Nausea) had resolved and MALAISE (Feeling unwell), STRESS (Stress), DISCOMFORT (Discomfort) and INJECTION SITE PAIN (Injection site burning) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.